Drug Type CAR-T |
Synonyms- |
Target |
Action antagonists |
Mechanism EGFRvIII antagonists(Epidermal growth factor receptor variant III antagonists), Gene transference(Gene transference), T lymphocyte replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glioblastoma Multiforme | Phase 1 | United States | 30 May 2018 | |
Gliosarcoma | Phase 1 | United States | 30 May 2018 | |
Recurrent Glioblastoma | Phase 1 | United States | 30 May 2018 | |
Glioblastoma | Phase 1 | - | - |
Phase 1 | 3 | sbfyyndcxv = riadowniaw kmhskwhyyy (uqlqxgsfku, koimawrusd - ddzpdgfmzd) View more | - | 24 Jul 2020 |